Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04542720 · ClinicalTrials.gov registry record

Decompression Versus Decompression and Fusion

A clinical trial of Adjacent Segment Disease, sponsored by Massachusetts General Hospital.

Recruiting
Registry status
96
Enrollment target
1
Study location

NCT04542720 is a study of Adjacent Segment Disease that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 96 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04542720, a study of Adjacent Segment Disease, is actively recruiting participants, sponsored by Massachusetts General Hospital.

RECRUITING
Registry status
96 participants
Enrollment target
1
Study location

Study Summary

Adjacent segment disease (ASD) in the lumbar spine is a well-known sequela of lumbar fusion surgery. The annual incidence of adjacent level re-operation is approximately 3% with a ten-year prevalence of 20-30%. Frequently, the surgical treatment involves decompression of the adjacent level coupled with extension of the instrumentation and fusion. Advocates of this paradigm cite the altered kinematics and biomechanics of levels adjacent to a lumbar fusion mass. Furthermore, decompressed levels adjacent to a fused segments are associated with higher rates of ASD in retrospective studies. Yet, a retrospective review of higher quality data concluded decompression adjacent to single-level fusion provides similar outcomes compared to fusions extending across the decompressed segments. Given the conflicting data currently available, higher quality data are needed to guide surgical decision-making in ASD. The purpose of this trial is to prospectively compare decompression and decompression with fusion in patients with lumbar ASD.

Conditions Studied

Interventions

  • PROCEDURE Observational: Decompression
  • PROCEDURE Observational: Extension Fusion

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 96 participants
Start Date 2020-09-01
Est. Completion 2027-09

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT04542720

The ClinicalTrials.gov registry entry for NCT04542720 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 96 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Adjacent Segment Disease appearing as the primary indexed condition, and to 2 interventions - of which Observational: Decompression is the first listed.

NCT04542720 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04542720 about?

NCT04542720 is a clinical study titled "Decompression Versus Decompression and Fusion". Adjacent segment disease (ASD) in the lumbar spine is a well-known sequela of lumbar fusion surgery. The annual incidence of adjacent level re-operation is approximately 3% with a ten-year prevalence of 20-30%. Frequently, the surgical treatment involves decompression of the adjacent level coupled w...

What is the current status of trial NCT04542720?

This trial is currently recruiting. The enrollment target is 96 participants. The study started on 2020-09-01. Estimated completion is 2027-09.

What conditions does trial NCT04542720 study?

This clinical trial studies the following conditions: Adjacent Segment Disease.

What interventions are being tested in trial NCT04542720?

The interventions under investigation include: Observational: Decompression (PROCEDURE), Observational: Extension Fusion (PROCEDURE).

Who is sponsoring clinical trial NCT04542720?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04542720 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.